Top Ranked Growth Stocks to Buy for June 28th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, June 28th:
Xcerra Corporation (XCRA): This test and handling capital equipment provider, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 4% over the last 60 days.
Xcerra Corporation Price and Consensus
Xcerra Corporation price-consensus-chart | Xcerra Corporation Quote
Xcerra has a PEG ratio of 1.11, compared with 1.89 for the industry. The company possesses a Growth Score of A.
Xcerra Corporation PEG Ratio (TTM)
Xcerra Corporation peg-ratio-ttm | Xcerra Corporation Quote
Dillard's, Inc. (DDS): This retail department stores operator, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.
Dillard's, Inc. Price and Consensus
Dillard's, Inc. price-consensus-chart | Dillard's, Inc. Quote
Dillard's has a PEG ratio of 1.53, compared with 9.26 for the industry. The company possesses a Growth Score of A.
Dillard's, Inc. PEG Ratio (TTM)
Dillard's, Inc. peg-ratio-ttm | Dillard's, Inc. Quote
International Paper Company (IP): This paper and packaging company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 2.8% over the last 60 days.
International Paper Company Price and Consensus
International Paper Company price-consensus-chart | International Paper Company Quote
International Paper has a PEG ratio of 1.09, compared with 1.51 for the industry. The company possesses a Growth Score of A.
International Paper Company PEG Ratio (TTM)
International Paper Company peg-ratio-ttm | International Paper Company Quote
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Xcerra Corporation (XCRA) : Free Stock Analysis Report
International Paper Company (IP) : Free Stock Analysis Report
Dillard's, Inc. (DDS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
